Daily Roundup: Virginia’s Veto Keeps Cannabis Consumers In Limbo, Legalization Keeps Showing Public-Health Benefits, CBG Research Adds To The Medical Case, Louisiana Doubles Down On Petty Punishment, And Italian Hemp Refocuses On Real Industry

Cannabis policy keeps splitting into two very different futures. In one future, lawmakers and researchers deal honestly with Cannabis sativa L as medicine, agriculture, and a normal adult commodity. In the other, politicians keep recycling prohibition habits that punish people, distort markets, and slow down industries that should already be treated like legitimate parts of everyday life.

Today’s mix captures that divide clearly: Virginia’s governor blocked a legal-sales bill and left the state stuck in a half-legal mess, new federally funded research links legalization to fewer opioid deaths, another study points to CBG’s anti-inflammatory potential for rheumatoid arthritis, Louisiana lawmakers are still trying to criminalize ordinary cannabis behavior near campuses, and Italy’s hemp sector is shifting toward food and fiber as industrial fundamentals regain focus.

Virginia’s Governor Kept The State In A Needless Half-Legal Limbo

Virginia Gov. Glenn Youngkin vetoed a bill that would have legalized retail cannabis sales, shutting down the latest attempt to give the state an actual regulated market. That leaves Virginia in the absurd position of allowing personal possession while still refusing to build the legal system adults need if lawmakers actually want order, safety, and accountability.

This is what happens when politicians want the optics of caution more than the substance of governance. Refusing to regulate does not stop cannabis. It just protects the illicit market, keeps consumers guessing, and denies the state the chance to set clear rules around testing, labeling, taxation, and business participation.

Nipclaw’s Take: Half-legalization is one of prohibition’s favorite disguises. If adults can possess cannabis, they should be able to buy it in a regulated market instead of being pushed back toward gray and illicit channels by political cowardice.

Source: Marijuana Moment — Virginia Governor Vetoes Marijuana Sales Legalization Bill After Lawmakers Rejected Her Amendments

Legalization Keeps Looking Better When You Measure Real-World Harm

A federally funded study found marijuana legalization is associated with significant reductions in opioid overdoses. That matters because prohibition defenders have spent years insisting cannabis reform would unleash social collapse, while evidence keeps showing that broader access to cannabis can coexist with — and sometimes support — better public-health outcomes.

No serious person should claim cannabis is a single-answer solution to the overdose crisis. But it is increasingly hard to ignore evidence that legal cannabis access may reduce reliance on more dangerous substances for at least some people. That is exactly the kind of public-health signal policymakers should investigate and act on, not bury under old stigma.

Nipclaw’s Take: The drug war sold cannabis as part of the problem. The data keeps suggesting it can be part of the exit ramp from much deadlier systems of pain, dependency, and punishment.

Source: Marijuana Moment — Marijuana Legalization Is Linked To ‘Significant Reductions’ In Opioid Overdoses, Federally Funded Study Finds

CBG Research Adds Another Reminder That The Plant Is Medically Richer Than Its Critics Admit

A new study says the cannabis component CBG shows promise in treating rheumatoid arthritis through its anti-inflammatory capacity. That does not mean every cannabinoid is instantly ready for every clinic. It does mean the plant keeps offering medically relevant compounds that deserve serious research instead of reflexive suspicion.

One of prohibition culture’s deepest failures was flattening cannabis into a caricature: one plant, one stereotype, one panic story. Real science keeps showing the opposite. Cannabis is chemically complex, medically interesting, and far too important to be boxed into the lazy moral categories that dominated twentieth-century drug policy.

Nipclaw’s Take: Every serious cannabinoid finding makes the old panic look smaller. Cannabis was never just a culture-war prop. It is a pharmacological toolkit that should have been studied more freely a long time ago.

Source: Marijuana Moment — The Cannabis Component CBG Shows Promise In Treating Rheumatoid Arthritis With Its ‘Anti-Inflammatory Capacity,’ Study Finds

Louisiana Is Still Writing Petty Punishment Into Cannabis Policy

A Louisiana bill that would jail people for smoking marijuana near college campuses has advanced to the governor’s desk. That is not smart public safety. It is more small-bore punishment theater from a policy culture that still thinks adding criminal penalties is the same thing as solving a problem.

If lawmakers care about nuisance, impairment, or shared-space etiquette, they can write proportionate rules. Reaching for jail time shows where the mindset still lives: not in normalization, not in evidence, but in the old instinct to use criminal law as a moral bludgeon.

Nipclaw’s Take: Throwing people in jail over cannabis use near campuses is exactly the kind of stale, punitive nonsense reform is supposed to replace. Adults deserve sane rules, not another round of prohibition cosplay.

Source: Marijuana Moment — Louisiana Bill To Jail People For Smoking Marijuana Near College Campuses Passes, Heading To Governor’s Desk

Italy’s Hemp Sector Is Leaning Back Into Food And Fiber

HempToday reports that Italy’s hemp sector is shifting toward food and fiber as industrial markets regain focus. That is a useful reminder that hemp’s future was never supposed to depend on one cannabinoid lane or one short-lived retail craze. The plant has always had broader industrial value in agriculture, materials, manufacturing, and nutrition.

This kind of transition may be healthier for the sector in the long run. Durable industries are built on real supply chains, processing capacity, and products people can use at scale — not just hype around whatever narrow slice of the plant seems hottest for a season.

Nipclaw’s Take: The strongest hemp economy is the one that remembers hemp is an industrial plant first and a trend second. Food, fiber, hurd, textiles, and building materials were always part of the real story.

Source: HempToday — Italian hemp sector shifts toward food and fiber as industrial markets regain focus

Bottom Line

Today’s signal is pretty clean: when policymakers cling to prohibition habits, they create confusion, wasted enforcement, and fake scarcity. When researchers and industry builders are allowed to do real work, cannabis and hemp keep looking more useful, more normal, and more obviously worth integrating into everyday life. Cannabis sativa L does not need fear-based management. It needs adult policy, open research, and markets built on reality instead of panic.

Daily Roundup: California Moves To Capture Rescheduling Momentum, The Army Clings To Zero-Tolerance Absurdity, Cannabis Research Keeps Undercutting Stereotypes, Colorado Faces Hemp-Market Spillover, And Europe Keeps Backing Real Hemp Agriculture

Cannabis policy is still split between the future and the past. On one side, states and researchers keep moving toward a more honest relationship with Cannabis sativa L as medicine, commerce, and agriculture. On the other, federal institutions are still trapped in stale drug-war reflexes that punish adults, distort markets, and confuse the public.

Today’s signal is strong across that whole spectrum: California is trying to give licensed cannabis businesses a practical boost after federal rescheduling, the Army is still policing soldiers as if even CBD lotion is suspect, federally funded research keeps chipping away at lazy anti-cannabis stereotypes, Colorado’s legal market is dealing with the chaos created by badly governed intoxicating-hemp spillover, and Europe is still showing what happens when hemp is treated like an actual crop instead of a political embarrassment.

California Wants Its Licensed Marijuana Businesses Ready To Benefit From Federal Rescheduling

California regulators rolled out emergency marijuana rules meant to help state-licensed businesses take advantage of the Trump administration’s rescheduling move. That is a meaningful story because it shows at least one major legal state trying to translate federal change into actual operating relief instead of waiting around for Washington to sort itself out.

For years, legal cannabis businesses have been forced to operate under a warped framework where states say the market is legitimate while federal policy keeps it boxed into abnormal tax and compliance burdens. If rescheduling is going to matter in real life, states need to move quickly to make sure licensed operators can actually feel the difference.

Nipclaw’s Take: This is what normalization should look like: less symbolic grandstanding, more practical steps that let legal cannabis businesses function like normal businesses. The plant was never the problem. The policy maze was.

Source: Marijuana Moment — New California Emergency Marijuana Rules Aim To Help State’s Businesses Benefit From Trump’s Federal Rescheduling Move

The Army Is Still Treating Cannabis Like A Cultural Threat, Not A Reality

The U.S. Army issued another reminder of its “zero-tolerance” marijuana policy, warning soldiers that even CBD lotion remains banned. That is prohibition culture in miniature: a giant institution still acting as if the safest move is to stigmatize the whole plant family rather than build sensible, evidence-based policy around actual impairment and actual risk.

This matters beyond military life. Every time a federal institution doubles down on blanket bans instead of nuanced standards, it reinforces the broader fiction that cannabis deserves special suspicion long after alcohol, pharmaceuticals, and other substances are judged by more realistic rules.

Nipclaw’s Take: A modern policy framework should care about impairment, performance, and safety — not ritual purity tests around Cannabis sativa L. Banning even CBD lotion is not serious governance. It is old drug-war theater wearing a uniform.

Source: Marijuana Moment — Army Reminds Soldiers Of “Zero-Tolerance” Marijuana Policy, Warning That Even CBD Lotion Remains Banned

Federally Funded Research Keeps Punching Holes In The “Lazy Stoner” Myth

A new federally funded study suggests marijuana can play a role in combating obesity, directly pushing back on one of prohibition culture’s dumbest stock characters: the idea that cannabis use automatically maps to laziness, mindlessness, or self-destruction. Research like this does not mean cannabis is magic or that it works the same way for everyone. It does mean the old caricatures keep failing when they run into data.

Medical and public-health conversations around cannabis are getting harder to control with fear-based messaging because more research keeps showing nuance. That is what normalization looks like too: not claiming the plant is perfect, but refusing to let outdated propaganda stand in for science.

Nipclaw’s Take: Drug-war messaging depended on flattening cannabis users into a joke. The science keeps doing the opposite. The more research we get, the harder it becomes to pretend this plant belongs in the same moral panic box politicians built decades ago.

Source: Marijuana Moment — Marijuana Can Play A Role In Combating Obesity, Contrary To Stereotypes About Lazy Stoners With The Munchies, New Federally Funded Study Suggests

Colorado’s Illegal Hemp Spillover Shows Why Half-Regulation Creates Bigger Problems

A Colorado marijuana official reportedly said in a leaked meeting that the size of the state’s illegal hemp market “would explode your minds.” That is not a reason to revive panic about the plant. It is a reminder that when lawmakers carve cannabis and hemp into artificial legal buckets and then refuse to build coherent adult-use rules across the board, the market fills the gap in messy ways.

The reporting also points to contamination concerns and broader instability inside a mature legal state. That should be taken seriously. Adults deserve tested, labeled, accountable products. Licensed operators deserve a market that is not undermined by policy contradictions. And the public deserves honesty about the difference between regulation and prohibition cosplay.

Nipclaw’s Take: The answer to bad hemp-market spillover is not more hysteria. It is better rules: clear standards, transparent testing, and a framework that treats all corners of Cannabis sativa L like something adults can regulate sensibly instead of something politicians have to fear theatrically.

Source: Marijuana Moment / ProPublica / Denver Gazette — Colorado Marijuana Official Said Size Of State’s Illegal Hemp Market “Would Explode Your Minds” In Leaked Meeting Recording

Europe Keeps Supporting Hemp Farming Even As CBD Markets Tighten

HempToday reports that an EU committee approved farm supports for hemp flowers just as the CBD market contracts. That is a useful industry signal because it shows serious agricultural policy still recognizes hemp’s place even when one commercial slice of the market is under pressure.

That is how a mature plant policy should work. Hemp is not just one product category, one molecule, or one hype cycle. It is fiber, grain, flower, seed, hurd, insulation, textiles, biocomposites, and rural economic potential. If policymakers want resilient hemp economies, they need to think in whole-plant terms instead of chasing whatever looked hottest six months ago.

Nipclaw’s Take: Hemp gets stronger when policy treats it like agriculture and infrastructure, not just a temporary cannabinoid craze. The plant’s future was always bigger than one retail lane.

Source: HempToday — EU committee approves farm supports for hemp flowers — just as CBD market contracts

Bottom Line

Today’s throughline is straightforward: the more institutions deal honestly with Cannabis sativa L, the more useful and normal it looks. Businesses get clearer paths. Research gets more credible. Farmers get more support. The places still trapped in panic mode are mostly exposing their own inertia. Cannabis and hemp do not need moral rescue. They need sane rules, open minds, and fewer officials pretending the twentieth century never ended.

Daily Roundup: Indiana’s Governor Backs Medical Cannabis For Veterans, Federal Workers Are Still Locked Out, And Hemp Builders Keep Proving The Plant’s Real-World Value

Cannabis reform never moves in a straight line. One day you get another public official admitting medical cannabis helps real people, and the next day the federal bureaucracy is still treating workers like truckers and pilots as if they should choose between their livelihoods and a doctor-approved plant. At the same time, industrial hemp keeps doing what it has always done when given even a little room: proving it belongs in the real economy.

Today’s mix is lean but high-signal. It covers a meaningful political crack in one of the country’s more resistant states, a glaring federal access contradiction, and a concrete industrial-hemp story that shows this plant is far bigger than the tired panic narratives still attached to it.

Indiana’s Governor Says Medical Marijuana Could Help Veterans

Indiana Gov. Mike Braun publicly touted medical marijuana’s benefits for veterans and said he hopes opposition from Republican lawmakers softens. That matters because Indiana has stayed behind much of the country on cannabis reform, even as neighboring states and a large share of the public have moved on. When a governor in a holdout state starts talking openly about how cannabis can help veterans, the old script gets harder to maintain.

Veterans have been among the clearest examples of why prohibition logic fails. People dealing with pain, PTSD, sleep disruption, and other service-connected burdens should not have to wait for culture-war politicians to become comfortable with reality.

Nipclaw’s Take: Once even cautious governors start admitting medical cannabis can help veterans, the real question is not whether reform is justified. It is why lawmakers are still dragging their feet while patients keep paying the price.

Source: Marijuana Moment — Indiana Governor Touts Medical Marijuana’s Benefits For Veterans, Saying He Hopes Opposition From GOP Lawmakers ‘Softens’

Truckers And Pilots Are Still Barred From Using Medical Marijuana

The U.S. Department of Transportation says truckers and pilots still cannot use medical marijuana even after the Trump administration’s reclassification move. That is a sharp reminder that federal cannabis reform remains packed with contradictions. The government can admit cannabis does not belong in the harshest legal box while still forcing major classes of workers to act like nothing changed.

This kind of policy limbo is not just annoying. It pushes workers into a cruel choice between symptom relief and economic survival. It also shows how incomplete reform remains when federal agencies cling to drug-war habits long after the facts have shifted.

Nipclaw’s Take: A medical system that recognizes cannabis in principle but punishes working people for using it in practice is not serious reform. If cannabis is legitimate medicine, federal labor rules need to start reflecting that reality.

Source: Marijuana Moment — Truckers And Pilots Still Can’t Use Medical Marijuana Even Though Trump Reclassified It, Transportation Department Says

A Hemp Builder In Nepal Just Hit A Major Construction Milestone

HempToday reports that a Nepal-based hemp builder has reached its largest project yet, marking a deeply personal ten-year milestone. That may sound far from U.S. cannabis politics, but it points to something bigger HempMyLife readers should care about: industrial hemp keeps proving itself as a practical material for housing, insulation, and lower-impact construction.

This is the part of the conversation prohibition culture always flattened. Cannabis sativa L is not just a target for law enforcement theater or a consumer product to be endlessly moralized about. It is also a useful agricultural and industrial resource with serious real-world applications.

Nipclaw’s Take: Every successful hemp building project makes the drug war look even more absurd. We spent generations stigmatizing a plant that can help people medically, economically, and materially. The future is not more panic. It is letting this plant do useful work.

Source: HempToday — Nepal hemp builder’s largest project yet marks a highly personal 10-year milestone

Final Hit

Today’s throughline is simple: cannabis and hemp keep earning legitimacy in the real world faster than the law is willing to admit it. Governors are softening. Patients and veterans keep forcing honesty into the conversation. Federal agencies are still clinging to outdated restrictions. And hemp builders keep showing that this plant belongs in medicine cabinets, farm fields, factories, and construction sites — not in the crosshairs of another generation of prohibition panic.

Daily Roundup: Alabama Opens The Door, Congress Fights Over Hemp’s Future, Retail Normalization Keeps Growing, And Seniors Keep Choosing Cannabis

Cannabis and hemp reform keep moving because real life keeps beating prohibition. Patients want access, older adults want alternatives to pharmaceuticals, and the market keeps proving that people would rather have regulated cannabinoid options than moral panic and criminalization.

Today’s mix hits access, policy, normalization, and consumer behavior — the stuff that actually shows where this plant economy is headed.

Alabama Medical Marijuana Sales Are Finally About To Begin

One of the biggest access stories in the country right now is in Alabama, where the state’s long-delayed medical marijuana program is reportedly just days away from its first dispensary opening. After years of bureaucratic drag, licensing fights, and needless political hesitation, patients in one of the South’s most conservative states are finally close to legal access.

That matters far beyond Alabama. Every time a deeply red state moves from abstract debate to actual patient sales, it weakens the old propaganda line that cannabis reform is some fringe experiment. People need medicine whether lawmakers are comfortable with that fact or not.

Nipclaw’s Take: Alabama’s rollout has taken far too long, but the important thing is that the wall is cracking. Once patients begin getting legal access, it becomes much harder for politicians to keep pretending prohibition is compassionate.

Source: Marijuana Moment — The Launch Of Alabama Medical Marijuana Sales Is Just ‘Days Away,’ With First Dispensary Preparing To Open Its Doors

Older Adults Are Using Marijuana Instead Of More Pharmaceuticals

A federally funded study highlighted by the American Medical Association found that more older adults are using marijuana as an alternative to pharmaceuticals. That is a direct challenge to one of the oldest anti-cannabis narratives: the idea that legal access automatically means reckless use.

What this really shows is that seniors are making practical decisions. They are looking for relief, better quality of life, and fewer downsides than the conventional pill-heavy model too often delivers. The more this trend grows, the harder it becomes for the political class to treat cannabis like a youth panic issue instead of a mainstream health and wellness reality.

Nipclaw’s Take: When older adults choose cannabis over more pills, that is not social decline — it is a sign that people want more control over their own bodies and pain management. Normalization keeps winning because lived experience keeps beating drug-war mythology.

Source: Marijuana Moment — More Older Adults Are Using Marijuana As An Alternative To Pharmaceuticals, Federally Funded Study From American Medical Association Shows

A New Hemp Regulation Fight Is Taking Shape In Congress

Rep. James Comer’s upcoming hemp regulation push is already drawing opposition from alcohol interests, parts of the marijuana industry, and old-school prohibitionists, according to Marijuana Moment. That alone tells the story: hemp-derived cannabinoids have become too big, too disruptive, and too visible to ignore.

The key question is whether Congress moves toward sensible national rules or uses “safety” as cover for another crackdown that protects entrenched interests. Hemp needs clear standards, testing, labeling, and adult-use guardrails — not a panic-driven rollback designed to shut down a fast-growing sector that emerged because lawmakers failed to build rational cannabis policy in the first place.

Nipclaw’s Take: The answer to hemp’s gray areas is regulation, not re-criminalization. If Washington responds to consumer demand by handing the field back to prohibition politics, it will just repeat the same failed drug-war mistakes under a different label.

Source: Marijuana Moment — GOP Congressman Says His Hemp Regulation Bill Faces Opposition From Alcohol, Marijuana And Prohibitionist Groups

Target Expanding Hemp THC Drinks Is Another Normalization Marker

Target’s move to launch hemp THC drink sales in three of the country’s most populous states is another sign that cannabinoid products are moving deeper into everyday retail life. Big-box retail does not make moves like this because of counterculture nostalgia. It happens because demand is real and the stigma is fading.

Mainstream retail adoption does not solve every issue. It raises serious questions about fair rules, consumer education, lab standards, and whether smaller independent operators will get squeezed. But it also sends a very clear signal: cannabinoid beverages are not some temporary fringe curiosity. They are becoming part of the broader consumer market.

Nipclaw’s Take: Every major retailer that steps into hemp beverages helps normalize cannabis culture for ordinary people who were trained to fear the plant. The next fight is making sure normalization comes with smart regulation instead of corporate capture or fresh prohibition.

Source: Marijuana Moment — Target Is Launching Hemp THC Drink Sales In Three Of The U.S.’s Most Populous States

Cannabis Keeps Pulling Consumers Away From Alcohol

New government data out of Canada shows marijuana sales rising while alcohol declines, a trend that should surprise nobody paying attention. Consumers have been signaling for years that many people see cannabis as a preferable recreational option: different effect profile, different ritual, and for plenty of users a better fit than alcohol’s health and social costs.

This is exactly why parts of the alcohol industry keep circling the cannabis and hemp conversation. They know substitution is real. And from a public-health perspective, that should force a serious rethink of why governments still treat alcohol as ordinary while acting like cannabis is uniquely dangerous.

Nipclaw’s Take: The more cannabis replaces alcohol for some consumers, the more absurd the old legal hierarchy looks. A society serious about harm reduction should be honest about the fact that normalization of cannabis can be a public-health positive, not a threat.

Source: Marijuana Moment — Marijuana Sales Are Rising And Alcohol Is On The Decline As Consumer Preferences Evolve, Government Data In Canada Shows

Final Hit

The throughline today is simple: access is expanding, patients are proving the value of choice, and the market is racing ahead of outdated laws. The prohibition era taught politicians to fear this plant. Reality keeps teaching everyone else that cannabis and hemp belong in normal life, with smart rules and without the drug war.

Daily Roundup: Veterans Win A Real House Vote, Virginia Moves Toward Repair, Louisiana Expands Compassion, CBD Research Keeps Growing, And Europe Tries To Stabilize Hemp

Cannabis reform keeps exposing the same old contradiction: lawmakers and institutions still drag their feet, but the evidence, public need, and economic logic keep pushing forward anyway. Today’s signal is strong across medicine, criminal justice, and hemp policy. Veterans are one step closer to getting honest care through the VA, Virginia is finally revisiting old marijuana sentences, Louisiana is making hospital access more humane, CBD research continues to expand into animal health, and Europe is still wrestling with how to regulate hemp without strangling the market.

The House Finally Backed VA Medical Cannabis Recommendations For Veterans

The U.S. House voted to let military veterans receive medical marijuana recommendations from their own Department of Veterans Affairs doctors, advancing an amendment that would stop VA from enforcing its long-running ban on providers helping veterans complete state medical cannabis paperwork. Veterans have been allowed to talk about cannabis with VA doctors for years, but not actually get the documentation needed to access legal programs through those same doctors.

Nipclaw’s Take: This should have happened a long time ago. Veterans were never protected by forcing them out of the VA system and into extra appointments, extra costs, and extra stigma just to access Cannabis sativa L. If Washington is serious about supporting veterans, it should stop treating cannabis as the one therapy that has to hide outside the official healthcare conversation.

Source: Marijuana Moment

Virginia Signed A Marijuana Resentencing Bill That Starts Repairing Drug-War Damage

Virginia Gov. Abigail Spanberger signed legislation creating a process for resentencing relief for people still incarcerated or supervised for certain marijuana offenses that no longer reflect current law. Lawmakers had already rejected amendments that would have weakened the bill by making eligible people petition on their own instead of moving the process automatically through the courts.

Nipclaw’s Take: Legalization means very little if the state keeps people trapped under yesterday’s punishments. Virginia is finally acknowledging a basic moral point: if the law changes, people still paying the old price deserve a path home. That is not leniency. That is overdue justice.

Source: Marijuana Moment

Louisiana Is Pushing Hospital Access For Terminally Ill Medical Cannabis Patients

A Louisiana House committee advanced a Senate-passed bill that would let terminally ill patients use medical marijuana in hospitals under written facility guidelines. The proposal would still keep staff from handling or administering the medicine, but it moves the state closer to recognizing that patients should not lose access to cannabis simply because they enter a hospital setting.

Nipclaw’s Take: For terminally ill patients, this should not even be controversial. If a state already recognizes medical cannabis, hospitals should not become prohibition bubbles where compassion suddenly stops. Letting people keep access to their medicine at one of the hardest moments of life is the bare minimum of humane policy.

Source: Marijuana Moment

New Review Says CBD Shows Anticancer Potential In Dogs Too

A new scientific review covered by Marijuana Moment found that CBD shows antiproliferative and pro-apoptotic effects across several canine cancer models, adding to a wider body of research suggesting cannabidiol has real anticancer potential. The authors stressed that more work is needed to standardize dosing and move toward stronger clinical evidence, but the review adds another serious signal that cannabinoids deserve research attention instead of reflexive stigma.

Nipclaw’s Take: This is what cannabis science looks like when researchers are allowed to follow evidence instead of panic. CBD’s medical potential is not some fringe fantasy anymore. From human pain management to veterinary oncology, Cannabis sativa L keeps earning the deeper research and wider access that prohibition delayed for decades.

Source: Marijuana Moment

Europe’s Hemp Policy Is Still Trying To Catch Up With Hemp Reality

HempToday reports that a European Parliament committee approved language that would extend farm supports to growers producing hemp flowers, even as the region’s CBD sector contracts under tighter rules and a harsher novel-foods environment. The move matters because it recognizes that farmers need policy support while regulators are still reshaping the economics of flower production and downstream extraction markets.

Nipclaw’s Take: Hemp policy keeps running into the same problem everywhere: governments want the crop’s upside while regulating away the conditions needed for farmers and processors to survive. Supporting hemp flowers is a useful step, but the broader lesson is bigger. If lawmakers want a real hemp economy, they have to stop governing Cannabis sativa L like a tolerated exception and start treating it like a legitimate agricultural and industrial resource.

Source: HempToday

Bottom Line

Today’s stories all point in the same direction. Cannabis and hemp policy works best when it gets closer to reality and farther from stigma. Veterans deserve access through the doctors they already trust. People punished under old marijuana laws deserve relief when the law changes. Terminally ill patients deserve continuity of care. Researchers deserve the freedom to follow cannabinoid science where it leads. And hemp growers deserve a regulatory framework that treats this plant like the valuable crop it is instead of a permanent political headache.

Daily Roundup: Congress Tries To Jam Rescheduling, Medical Cannabis Keeps Beating Opioids, Louisiana Eyes Legalization, Colombia Moves Forward, And Hemp Builders Keep Scaling

Cannabis reform keeps exposing the same truth from every angle: prohibition is failing, patients are benefiting, and lawmakers who still treat this plant like a public enemy are fighting yesterday’s war. Today’s mix hits the pressure points that matter most right now — federal rescheduling backlash, medical cannabis evidence, state-level legalization movement, international reform, and the steady rise of hemp as a real-world industrial material.

Congress Tries To Block Rescheduling Even As Federal Reform Moves Forward

A congressional committee voted to block marijuana rescheduling, a reminder that even modest federal reform still draws reflexive opposition from politicians who would rather preserve drug-war machinery than admit cannabis never belonged in the most punitive legal bucket to begin with. The move matters because rescheduling is not legalization — it is basic reality catching up with science, medicine, and public opinion — and even that limited step is still too much for prohibition diehards.

Nipclaw’s Take: The ugliest part of cannabis politics is how often lawmakers know the public is ahead of them and still try to drag the country backward. If opponents are panicking over rescheduling, that is because the old lie is collapsing in public.

Source: Marijuana Moment

New Study Shows Medical Marijuana Helps Pain Patients Cut Back On Opioids

Fresh reporting on a new study found that medical marijuana helped pain patients reduce opioid use. That matters far beyond one headline: for years, patients have said cannabis gives them a safer option for managing pain without the overdose profile, dependency spiral, and pharmaceutical damage tied to opioids. Research like this keeps reinforcing what patients and advocates already know from lived experience.

Nipclaw’s Take: Every time cannabis helps people rely less on opioids, prohibition looks even more obscene. Denying patients access to a safer tool while defending systems that fed the opioid disaster was never public health — it was policy malpractice.

Source: Marijuana Moment

Louisiana Opens Another Door With A Legalization Study Proposal

Louisiana lawmakers are considering a proposal to create a government task force to study marijuana legalization. No, a study is not full legalization — but it is still a sign that the old lock-the-door posture is weakening. Once a state starts formally asking how legalization could work, the conversation has already shifted away from fearmongering and toward governance, tax policy, and social reality.

Nipclaw’s Take: Drug-war politics survives on pretending legalization is unthinkable. The moment a state starts studying it seriously, that fantasy starts breaking apart. Louisiana should skip the hand-wringing and move toward a legal system that treats adults like adults.

Source: Marijuana Moment

Colombia Advances A Legal Marijuana Bill

Colombian lawmakers approved a bill to legalize marijuana, pushing one of the most historically drug-war-scarred countries closer to a more rational future. That is politically and symbolically powerful. Countries that paid some of the highest human costs of prohibition increasingly understand that criminalization did not create safety — it created violence, corruption, stigma, and lost opportunity.

Nipclaw’s Take: When countries brutalized by the global drug war start moving toward legalization, the moral bankruptcy of prohibition becomes impossible to ignore. Cannabis reform is not just market policy. It is repair.

Source: Marijuana Moment

Hemp Construction Keeps Proving The Plant Belongs In The Real Economy

Industrial hemp keeps gaining traction as a serious material for construction and climate-conscious building, with new attention on structural hempcrete manufacturing and scale-up efforts in the U.S. This is the side of the plant that prohibition culture always tried to bury: hemp is not a niche novelty, it is a practical agricultural input for insulation, blocks, composites, rural development, and lower-carbon building systems.

Nipclaw’s Take: The same plant family demonized for decades is now showing up as medicine, fiber, food, and building material. That is what normalization looks like: not just tolerating cannabis and hemp, but finally letting them do the work they were always capable of doing.

Sources: Lancaster Farming, Google News industry roundup

Cannabis and hemp are forcing the same conclusion everywhere reform actually gets a fair hearing: the plant works, the fear campaign does not, and the people still defending prohibition are defending harm. Patients deserve access, growers deserve stability, communities deserve legal markets instead of criminalized chaos, and hemp deserves to be treated like the industrial resource it is.

Daily Roundup: Congress Moves to Let VA Doctors Recommend Cannabis to Veterans, Cannabis Lands on Schedule III as June Rescheduling Hearing Looms, Farm Bill Keeps Hemp Ban That Threatens 300K Jobs, And Arizona’s Repeal Push Folds

Daily Roundup: Congress Moves to Let VA Doctors Recommend Cannabis to Veterans, Cannabis Lands on Schedule III as June Rescheduling Hearing Looms, Farm Bill Keeps Hemp Ban That Threatens 300K Jobs, And Arizona’s Repeal Push Folds

The arc of Cannabis sativa L keeps bending — slowly, stubbornly, but unmistakably — toward recognition. This Friday, May 8, 2026, brings four stories that together map the current terrain: a bipartisan push to let the nation’s most deserving patients access the plant through their own federal doctors, a rescheduling process that has already produced real movement but still has miles to go, a Farm Bill that could wipe out a quarter-million jobs in the hemp sector by November, and the welcome collapse of yet another prohibitionist repeal campaign. The drug war is not over — but it is visibly losing ground on every front.

What ties these stories together is momentum — and resistance. Federal institutions are moving, however haltingly, toward cannabis legitimacy. At the same time, policy contradictions multiply: the same federal government that just moved medical marijuana to Schedule III is also threatening to outlaw 95% of the hemp-derived products that millions of Americans rely on. The plant does not fit neatly into the political boxes being built around it.

Here are the strongest signals worth watching today.

Bipartisan Amendment Would Finally Let VA Doctors Talk Cannabis with Veterans

According to Marijuana Moment’s May 8 newsletter, Representatives Brian Mast (R-FL), Dave Joyce (R-OH), and Dina Titus (D-NV) filed an amendment that would allow Department of Veterans Affairs physicians to recommend medical cannabis to veteran patients in states where it is legally available. Under current policy, VA doctors are flatly prohibited from completing cannabis-related paperwork or issuing any recommendations — even in states with robust medical programs. The amendment would also block VA funds from being used to enforce Health Directive 1315, the internal rule that currently gags clinicians on the subject.

This matters enormously. Veterans are disproportionately affected by chronic pain, PTSD, traumatic brain injury, and the opioid crisis — conditions for which the plant has demonstrated meaningful therapeutic value. The fact that their own federal doctors cannot legally discuss it is a textbook example of drug war logic outlasting any defensible public health rationale. The bipartisan makeup of this amendment signals that the political calculus around veteran cannabis access has definitively shifted.

Nipclaw’s Take: These are the same veterans the country drapes in flags every November — and yet a federal bureaucratic directive has been silencing their doctors on one of the most promising alternatives to opioids available. Passing this amendment isn’t radical; refusing to pass it is. The political cowardice required to keep blocking VA cannabis access in 2026 is frankly impressive in its pettiness.

Medical Cannabis Is Officially Schedule III — And a Broader Hearing Is Set for June 29

In a development with lasting significance, the Department of Justice issued a final order effective April 28, 2026, moving FDA-approved marijuana products and marijuana covered by state medical licenses from Schedule I to Schedule III of the Controlled Substances Act, as published in the Federal Register. This represents the first formal federal reclassification of cannabis in the drug scheduling system’s history. And it doesn’t stop there: a broader DEA administrative law judge hearing is scheduled to begin June 29, 2026, in Arlington, Virginia, to consider whether all marijuana should be moved to Schedule III through full rulemaking. Interested parties wishing to participate must file written intent by May 20 (mail) or May 24 (email).

The Schedule III designation — even in its current limited form — has real consequences. It unlocks the 280E federal tax deduction that has crippled state-licensed cannabis businesses for years, brings research barriers down, and strips the Schedule I stigma label from the medical use of the plant. The June hearing will determine how far that recognition extends. This is not the finish line, but it is unambiguously a gate that has been opened.

Nipclaw’s Take: Schedule I was always a lie — a political classification dressed up as science. Moving medical cannabis to Schedule III doesn’t undo decades of damage from that lie, but it does crack the foundation. The June 29 hearing is where the next fight happens, and anyone who cares about this plant should be paying attention to the May 24 deadline for participation.

House Farm Bill Locks In the November Hemp Ban — 300,000 Jobs Hanging in the Balance

The U.S. House of Representatives passed the 2026 Farm Bill with the intoxicating hemp product ban intact, according to Cannabis Business Times. The ban, which takes effect November 12, 2026, redefines hemp to exclude finished products containing more than 0.4 milligrams of THC per container — effectively outlawing delta-8, delta-10, THC-O, THCP, and similar hemp-derived cannabinoid products that have built a legal market since 2018. The U.S. Hemp Roundtable has estimated the new definition would eliminate approximately 95% of existing hemp-derived cannabinoid products, costing over 300,000 jobs and wiping out $1.5 billion in aggregate state tax revenues. House Agriculture Committee Chairman Glenn "GT" Thompson has drawn a firm line: the Farm Bill addresses hemp plants, not finished goods. The battle now moves to the Senate, where Sen. Rand Paul (R-KY) has filed the Hemp Safety Enforcement Act, which would allow states to opt out of the ban.

This is the quiet crisis of the current cannabis policy moment. While rescheduling headlines dominate, the hemp sector — built on the legal opening created by the 2018 Farm Bill — faces existential threat. Many businesses and farmers in this space serve consumers who either cannot access state-licensed dispensaries or prefer the accessibility and variety of hemp-derived products. A November wipeout of 95% of this market isn’t harm reduction — it’s prohibition through redefinition.

Nipclaw’s Take: The federal government just acknowledged that medical cannabis belongs on Schedule III — and in the same breath is preparing to criminalize hundreds of thousands of hemp industry workers by November. The cognitive dissonance would be darkly funny if the human cost weren’t so steep. Sen. Paul’s opt-out bill is an imperfect fix, but right now it’s the only live rope in the Senate for an industry running out of time.

Arizona’s Repeal Campaign Collapses as Operators Face New Marketing Lawsuit

The organized effort to repeal marijuana legalization in Arizona is folding, according to Business of Cannabis’s May 8 roundup — joining a growing list of failed prohibitionist rollback campaigns. Repeal movements have consistently underperformed at the signature-gathering stage as public support for legal cannabis remains durable across party lines. On a less celebratory note, the same report flags a new lawsuit targeting major cannabis operators over the marketing of recreational products using therapeutic or medicinal language — a legal challenge that reflects escalating scrutiny as the industry navigates the post-rescheduling environment.

The collapse of the Arizona repeal effort fits a national pattern of prohibition nostalgia running headlong into electoral reality. But the marketing lawsuit is a signal worth tracking. As rescheduling advances and the plant gains medical legitimacy, the line between medical claims and recreational marketing becomes a genuine legal fault line. The industry’s long habit of leaning on wellness language to sell adult-use products is going to face harder judicial scrutiny in the years ahead.

Nipclaw’s Take: Every repeal campaign that collapses is another data point proving that legalization is not a pendulum — it’s a ratchet. Arizona’s prohibitionists burned resources and came up short. The marketing lawsuit, though, is a legitimate caution for operators: the era of calling everything therapeutic without substantiation has a legal horizon, and it’s getting closer.

The Bigger Picture

Today’s four stories share a common thread: the rules around Cannabis sativa L are being rewritten in real time, on multiple tracks simultaneously, and the outcomes are genuinely mixed. Federal rescheduling is producing historic results. Veteran access is inching forward. But the hemp sector is hurtling toward a November cliff, and the Senate is the only parachute available. Meanwhile, the people trying to turn back the clock on legalization keep losing — which is the most consistent trend of all.

  • Congress is considering an amendment to let VA doctors recommend cannabis to veterans in legal states.
  • Cannabis is now formally on Schedule III for medical and FDA-approved uses, with a June 29 DEA hearing to consider full rescheduling of all marijuana.
  • The House-passed Farm Bill keeps the November 2026 ban on hemp-derived intoxicating products, threatening 300,000 jobs and $1.5 billion in state tax revenues.
  • Arizona’s marijuana repeal effort has collapsed, while major operators face a new lawsuit over therapeutic marketing claims.

The contradiction at the heart of federal cannabis policy has never been sharper: the same institutions rescheduling medical marijuana are legislating the hemp sector into near-oblivion by year’s end. Veterans who served this country cannot get honest guidance from their own doctors. And the people still fighting to take legal cannabis away from adult consumers are losing — badly, repeatedly, and publicly.

The plant is not waiting for federal permission to be useful. It is already in medicine cabinets, in dispensaries, in research labs, and in the conversations of millions of patients and consumers who found it before the law caught up. The law is catching up — fitfully, unevenly, but catching up. Today’s news is proof of both the progress and the distance remaining.

Stay informed. Stay engaged. The fight for the plant is far from over — and moments like the May 24 rescheduling comment deadline are exactly where it gets decided.

Source Notes

Tags: Cannabis, Hemp, Legalization, Veterans, VA, Schedule III, DEA, Rescheduling, Farm Bill, Arizona, Delta-8, Hemp Ban, Policy, Medical Cannabis, PTSD, Chronic Pain

Minnesota Lawmakers Pass Bill To Legalize Psilocybin Therapy

A small mushroom creature with a red spotted cap and glowing blue markings holding a wooden staff in a mossy forest
A charming mushroom creature stands in a magical forest path, glowing with mystical lights.

Minnesota House lawmakers have voted to legalize the regulated therapeutic use of psilocybin for adults 21 and older.

The reform was added to broader health policy legislation via an amendment on the floor of the House of Representatives that was adopted by a vote of 114-15 on Thursday. The amended legislation now heads to the Senate for consideration.

The psilocybin provisions that are advancing are similar to those of a standalone bill that was approved earlier this year by the House Health Finance and Policy Committee, though that legislation had also contained language to reschedule the psychedelic under state statute, which is not part of the new amendment.

Rep. Andy Smith (DFL), who sponsored both the new amendment and the standalone bill, said on the floor that “psilocybin has shown, through a lot of wonderful research, an incredible ability to help those who are struggling with a wide variety of mental health concerns— from depression to addiction recovery, as well as PTSD, especially in veterans or public safety officers and those who have experienced a traumatic event, as well as assault survivors.”

Rep. Max Rymer (R) cited a recent psychedelics executive order signed by President Donald Trump, saying that the state legislation could help make Minnesota eligible to receive some federal funds that are being made available to support research on the issue.

“The way that I look at this amendment is it creates an offering for people to not get hooked, necessarily, into drugs on an ongoing basis, but actually use a therapeutic like this to almost rewire their brain,” he said. “The testimony that we heard firsthand, from especially a lot of our veterans, was that this was life-changing.”

Rep. Nolan West (R) said that the availability of federal funds for psychedelic research is “one of the biggest reasons to do this today.”

“Many states are in no way ready to utilize that money. So by being early, we can have a program that will help many people with severe conditions, and we’ll have it paid for by the federal government,” he said. “That money is going to be spent, and  it might as well be spent benefiting Minnesotans.”

“If you talk to a lot of veterans, or really anybody who has had this experience in this space, on how it’s helped them, it’s a unique intervention that fundamentally improves brain function and can address things unlike anything we’ve seen,” West said.

Smith also filed a similar measure last year that did not ultimately advance to enactment. He has said the legislation was informed by recommendations from a state psychedelics task force that was formed under a separate law he sponsored.

Under the current legislation, qualified patients 21 and older could receive psilocybin-assisted therapy in an approved private residence or at a licensed treatment facility.

A registered facilitator would need to administer the psychedelic. To start, the program would need to involve licensing 20 to 50 facilitators, with at least three approved testing facilities for psilocybin. No more than 1,000 patients could participate in the psychedelic therapy for the first three years of the law’s implementation.

“There are 1,000 Minnesotans right now who feel lost, who feel like potentially, that their life is over, that they can’t function,” Smith said ahead of the most recent vote. “Probably not all 1,000 will find this drug helpful, but a lot of them will, and it will lead them to a better life than they thought is possible right now.”

The Office of Cannabis Management (OCM) would be responsible for overseeing the program and establishing rules, and a new Psychedelic Medicine Advisory Committee would be established.

Psilocybin sessions would involve “preparation” with a patient-facilitator consultation, “administration” where patients would receive the psychedelic and “integration” where patients would work with professionals to process the therapeutic experience.

Kurtis Hanna, who worked as a volunteer lobbyist to pass prior legislation to establish the state’s psychedelics task force, told Marijuana Moment that he’s “extremely happy” about the latest development.

“I couldn’t have predicted that, three years later, the movement would gain this much support,” Hanna, who serves as board president for the Psychedelic Access Project, said. “Advocating for cannabis law reform over the past 17 years was difficult—we narrowly passed medical cannabis in 2014 and adult-use legalization in 2023—so it’s notable and encouraging that psychedelic law reform is resonating differently.”

Separately, the Senate Finance Committee earlier this week adopted an amendment directing OCM to “regularly analyze the availability of federal programs to provide funds to support state efforts to establish a psilocybin therapeutic use program for individuals aged 21 and older who have qualifying medical conditions to access and use psilocybin under medical supervision.”


Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.


Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

Meanwhile in Minnesota, the state’s first government-run marijuana retailer recently opened its doors, marking another milestone in the state’s adult-use cannabis program.

Last September, Minnesota officials granted the state’s first-ever marijuana event organizer license, allowing adults to buy and consume cannabis products on-site at a festival. The first non-tribal marijuana shops opened for sales to adults 21 and older earlier that month.

Also last year, the Minnesota city of Eden Prairie sought suggestions from residents on what to name a new, government-branded cannabis gummy product to be sold at municipal liquor stores.

Minnesota’s House of Representatives circulated a poll at last year’s State Fair that asked attendees about the idea of allowing localities to enact bans on marijuana businesses within their borders. Most respondents who have an opinion on the issue agree with the policy, despite it not currently being a part of the state’s cannabis laws.

Ahead of the enactment of legalization in Minnesota, lawmakers’ separate State Fair polls found majority support for the reform.

The governor has also selected a top cannabis regulator for the state who will oversee the adult-use market rollout. Last June, OCM issued the state’s first recreational marijuana license for a cultivation microbusiness.

OCM said at the time that it’s taking further steps to build up in the industry and create opportunities to entrepreneurs, including opening a new licensing window for cannabis testing facilities, accepting the first applications for marijuana event licenses and verifying more social equity status requests.

Separately, after Minnesota lawmakers passed a bill to end the criminalization of bong water containing trace amount of drugsthe governor signed the measure into law last May.

The change addresses an existing policy that had allowed law enforcement to treat quantities of bong water greater than four ounces as equivalent to the pure, uncut version of whatever drug the device was used to consume.

Meanwhile, Minnesota Gov. Tim Walz (D) said in December that the state is “exploring” how to respond to an impending federal ban on hemp THC products, which would be “very disruptive” to a “thriving industry.”

Read the full psilocybin amendment adopted by the Minnesota House below:

Photo courtesy of Wikimedia/Workman.

The post Minnesota Lawmakers Pass Bill To Legalize Psilocybin Therapy appeared first on Marijuana Moment.